What is Bonus BioGroup Ltd?
, a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 151.83M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.